Pharmaceutical Executive September 9, 2022

And, in equal measure, patients and doctors—as EU mulls new rules.

The announcement of a new EU plan for wider sharing of health data has won endorsement from across the health community—but this is sensitive territory, so unsurprisingly the detailed reactions vary widely, depending on whether it’s industry, patients, or healthcare professionals doing the talking.

Predictably, pharmaceutical companies in this familiar battle-ground are keen to get their hands on as much data as possible to further their own product development plans. Equally predictably, patients and doctors tend to focus on protecting privacy and ensuring data security. What is surprising this time round is that the proposal has prompted the expression of strong opinions on a previously unexplored area of health-data...

Today's Sponsors


Today's Sponsors

Upfront Healthcare

Today's Sponsor

Curation Health

Topics: Big Data, Biotechnology, Pharma, Pharma / Biotech, Technology
Biden’s New Executive Order Could Usher in an Era of Fair and Equitable Drug Pricing
Claims That RSV Surge Due To Covid-19 Vaccines Take Clinical Trial Data Out Of Context
Mark Cuban in talks with hospitals to solve drug shortages
Why should pharma invest in digital products for those living with rare diseases?
FDA approves most expensive drug on market